Committed to sharing our science

Committed to sharing our science

391 results available

Safety and Efficacy of Aficamten in Patients with Nonobstructive Hypertrophic Cardiomyopathy: A 96-week Analysis From FOREST-HCM

Oral Presentation, HFSA 2025

Masri, A et al.

September 28, 2025
Divergent Effect of Aficamten Versus Metoprolol on Exercise Performance in Obstructive Hypertrophic Cardiomyopathy: A Prespecified Analysis of MAPLE-HCM

Oral Presentation, HFSA 2025

Lewis, GD et al.

September 28, 2025
Effect of Aficamten Compared with Metoprolol on Echocardiographic Measures in Symptomatic Obstructive Hypertrophic Cardiomyopathy: MAPLE-HCM

Journal of the American College of Cardiology

Hegde, SM et al.

August 31, 2025
Effect of Aficamten Compared with Metoprolol on Cardiac Structure and Function in Symptomatic Obstructive Hypertrophic Cardiomyopathy: A Prespecified Analysis of MAPLE-HCM

Oral Presentation, ESC 2025

Hegde, SM et al.

August 31, 2025
Low Incidence of Atrial Fibrillation in Patients with Obstructive HCM Treated with Aficamten: An Analysis From the REDWOOD-HCM, SEQUOIA-HCM and FOREST-HCM Trials

Heart Rhythm

Rowin, EJ et al.

August 31, 2025